Back
Cue Biopharma 10K Form
Sell
16
CUE
Cue Biopharma
Last Price:
1.04
Seasonality Move:
13.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CUE News And Ratings
See the #1 stock for the next 7 days that we like better than CUE
CUE Financial Statistics
Sales & Book Value
| Annual Sales: | $5.49M |
|---|---|
| Cash Flow: | $-7.53M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.42 |
| Price / Book: | 2.75 |
Profitability
| EPS (TTM): | -0.91000 |
|---|---|
| Net Income (TTM): | $-44.61M |
| Gross Margin: | -- |
| Return on Equity: | -142.28% |
| Return on Assets: | -82.16% |
Cue Biopharma Earnings Forecast
Key Cue Biopharma Financial Ratios
- The Research & Development expenses have been 743.21% of Revenue.
- The Interest Expense is -2.45% of Operating Income.
- The Net Earning history of CUE is -924.10% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 4 years.
Cue Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CUE |
| CUSIP: | 22978P |
| Website: | cuebiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0.21 |
|---|---|
| Current Ratio: | 2.22 |
| Quick Ratio: | 2.12 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CUE Technical Analysis vs Fundamental Analysis
Sell
16
Cue Biopharma (CUE)
is a Sell
Is Cue Biopharma a Buy or a Sell?
-
Cue Biopharma stock is rated a Sell
The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.